We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Barth Syndrome Stem Cells Reveal Details of a Rare Heart Defect

By LabMedica International staff writers
Posted on 27 May 2014
Print article
Image: The series of images shows how inserting modified RNA into diseased cells causes the cells to produce functioning versions of the TAZ protein (from left, green), which correctly localize in the mitochondria (red). When the images are merged to demonstrate this localization, green overlaps with red, giving the third image a yellow color around its edges (Photo courtesy of Harvard University).
Image: The series of images shows how inserting modified RNA into diseased cells causes the cells to produce functioning versions of the TAZ protein (from left, green), which correctly localize in the mitochondria (red). When the images are merged to demonstrate this localization, green overlaps with red, giving the third image a yellow color around its edges (Photo courtesy of Harvard University).
Skin cells taken from Barth syndrome patients were used to generate stem cells that differentiated into defective heart tissue in culture.

Barth syndrome (type II 3-Methylglutaconic aciduria) is caused by mutation of the tafazzin gene. Tafazzin is responsible for remodeling of a phospholipid cardiolipin (CL), the signature lipid of the mitochondrial inner membrane. As a result, Barth syndrome patients exhibit defects in CL metabolism, including aberrant CL fatty acyl composition, accumulation of monolysocardiolipin (MLCL), and reduced total CL levels. About 120 cases of Barth syndrome, which is found exclusively in males, have been documented to date, but the syndrome is believed to be severely under-diagnosed and has been estimated to occur in one out of approximately 300,000 births.

Investigators at Harvard University (Cambridge, MA, USA) obtained skin cells from two Barth syndrome patients. The skin cells were induced to become stem cells carrying the patients’ TAZ mutations. The stem cells were cultured on chips lined with human extracellular matrix (ECM) proteins that mimicked their natural environment. Under these conditions the stem cells matured into a conglomerate of cardiomyocytes that mimicked heart tissue. Due to the presence of the TAZ mutations the heart tissue demonstrated very weak contractions, similar to a diseased human heart.

The investigators used this novel model system to define metabolic, structural, and functional abnormalities associated with TAZ mutation. They found that excess levels of reactive oxygen species (ROS) mechanistically linked TAZ mutation to impaired cardiomyocyte function. In addition, they used a gene therapy technique to provide the normal TAZ protein to the diseased tissue. Results published in the May 11, 2014, online edition of the journal Nature Medicine showed that inducing TAZ mutation in normal cardiomyocytes weakened contractions while addition of normal TAZ to the Barth syndrome cardiomyocytes corrected the contractile defect.

“The TAZ mutation makes Barth syndrome cells produce an excess amount of reactive oxygen species, or ROS—a normal byproduct of cellular metabolism released by mitochondria—which had not been recognized as an important part of this disease,” said senior author Dr. William Pu, associate professor of cardiology at Harvard University. “We showed that, at least in the laboratory, if you quench the excessive ROS production then you can restore contractile function. “Now, whether that can be achieved in an animal model or a patient is a different story, but if that could be done, it would suggest a new therapeutic angle.”

Related Links:

Harvard University


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Automated Nucleic Acid Extractor
eLab
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Genome sequencing technology has the potential to detect thousands of genetic disease (Photo courtesy of 123RF)

Gene Technology Outperforms Standard Newborn Screening Tests in Pioneering Study

Since its introduction in the 1960s, newborn screening has grown to encompass dozens of primarily genetic disorders. The standard approach to newborn screening involves detecting specific biomarkers in... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.